AKTS

Aktis Oncology, Inc.

NASDAQHealthcareBiotechnologyUS

USD24.63

+0.67 (+2.80%)

Rating:C+

CEO

Matthew Roden

IPO Date

2026-01-09

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Open

$23.76

Prev. Close

$23.96

Day Low

$23.76

Day High

$25.22

52W Low

$14.72

52W High

$34.19

Market Cap

$1.32B

Volume

0.24M

Annual Ratios

Date	Period	Gross Margin	Net Margin	ROE	ROA	D/E	Current Ratio	P/E
31 Dec 2025	FY	100.0%	-980.9%	43.6%	-24.1%	-0.08	7.37	-18.8
31 Dec 2024	FY	100.0%	-2957.6%	50.1%	-13.5%	-0.14	15.98

Quarterly Ratios

Date	Period	Gross Margin	Net Margin	ROE	ROA	D/E	Current Ratio	P/E
31 Mar 2026	Q1	79.8%	-567.9%	-3.6%	-3.2%	0.02	19.49	-13.6
31 Dec 2025	Q4	100.0%	-809.5%	10.4%	-5.7%	-0.08	7.37